바이오노트
₩4,635
▼ 5.00
(-0.11%)
Volume: 43,275
· 2026-09-23
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
46
- 21d momentum -3.7%
- RSI 40
🎯
Pullback
62
- Near lower Bollinger band
- -2.1% vs 20MA
💎
Value
70
- ROE 2.7%
- Op. margin 19.5%
- -26% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)39.9
MACD-18
MA trendMixed
ATR2.73%
21d mom.-3.7%
63d mom.+4.2%
vs 20MA-2.1%
RVOL(20)0.95×
52w low · 4,050
52w high · 6,300
-26.4% from 52-week high
20d support 4,500
· resistance 4,850
Computed live from daily OHLCV · as of 2026-09-23
🏦 Fundamentals
ROE2.7%
Op. margin19.5%
Net margin126.8%
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2023 | 0.1T | -0.0T | -52.2% |
| 2024 | 0.1T | 0.0T | 11.9% |
| 2025 | 0.1T | 0.0T | 14.1% |
| 2026 | 0.0T | 0.0T | 19.5% |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum -3.44%, daily vol 1.03%. 바이오노트 sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
-1억
Institution
+0억
Retail
+0억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-23 | -1 | +0 | +0 |
| 09-22 | -0 | +-0 | +0 |
| 09-21 | +0 | +-0 | -0 |
| 09-18 | -1 | -0 | +0 |
| 09-17 | -0 | +0 | +0 |
Net buy/sell in ₩100M (억). Positive = net buying.